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1. Introduction  
Q fever is a zoonosis caused by Coxiella burnetii, a small obligate intracellular Gram-negative 
pathogen worldwide spread, except New Zealand (Maurin & Raoult, 1999).  
Q fever has been described for the first time in 1935 as an outbreak of fever in workers of a 
slaughterhouse in Brisbane, Australia (Derrick, 1937). Derrick could not identify the 
aetiological agent therefore he defined the disease as “query fever”. Afterwards, in 1937, 
Burnet and Freeman (Burnet & Freeman, 1937) isolated a troublesome intracellular pathogen 
from mice inoculated with blood or feces from Derrick’s patients, and classified it as 
Rickettia burnetii. Only in 1948 Philip (Philip, 1948), according to cultural and biochemical 
characteristics, re-classified R. burnetii as a new genus, Coxiella, in honour of Herald R. Cox, 
who first isolated this microrganism in the USA. 
Ruminants and pets represent the most important reservoirs of the infection, and 
transmission to man mainly occurs through inhalation of contaminated aerosols. The 
disease is characterized by a wide clinical spectrum, varying from asymptomatic 
seroconversion, self-limiting febrile episodes to hepatitis and pneumonia. The illness can 
also occur in a chronic form, mainly characterized by endocarditis, and sometimes can have 
a lethal outcome. In contrast in animals C. burnetii infection is generally asymptomatic, even 
if infected animals can shed intermittently this pathogen in feces, urine, milk and birth 
products. Clinical symptoms eventually occurring in ruminant herds are mainly represented 
by reproductive disorders, such as premature birth, dead or weak offspring and infertility.  
2. Etiology 
Philogenetic and molecular studies based on the 16S rRNA sequences locate C. burnetii in 
the order of Legionellales, in the gamma group of Proteobacteria, next to bacteria such as 
Legionella spp., Francisella tularensis and Rickettsiella spp. (Raoult et al., 2005). In eukaryotic 
cells Coxiella replicates inside vacuoles, in mammals prefers monocytes and macrophages. 
This pathogen exhibits a complex intracellular cycle, characterized by the formation of 
spore-like forms. In infected cells it can be found in two different forms, one metabolically 
inactive, denominated SCV (“Small-Cell Variant”) and the other one metabolically active, 
LCV (“Large-Cell Variant”). The SCV form appears as a small and compact rod, and is 
highly resistant to physicochemical agents, such as desiccation and common disinfectants, 
therefore exhibiting high persistence in the environment. The LCV form is instead bigger 
and less dense if observed at the electronic microscope; it is metabolically active and can 
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differentiate in the SCV form through a sporogenic differentiation. Following cell rupture, 
the spore-like forms are released in the external environment where they can survive for 
long periods. 
When cultured on embrionated eggs or cell cultures, C. burnetii exhibits an antigenic 
variation associated with loss of virulence. Indeed this microrganism shows a pathogenic 
form denominated phase I, isolated from animal or human infected cells, and an avirulent 
form, denominated phase II, isolated after serial passages on embrionated eggs or cell 
cultures. The attenuated phase II is characterized by a deletion in the chromosome which 
causes the loss of some cell surface determinants (Maurin & Raoult, 1999).  
The association between specific characteristics of C. burnetii and the virulence of the strain 
is still an open controversial question, and several theories have been proposed to address 
the ability of different isolates to induce the acute or the chronic form of the disease. Several 
researchers tried to correlate the virulence to specific phenotypic and genetic profiles of the 
microorganism. In particular, SDS-PAGE analysis of the LPS isolated from the phase I 
allowed to identify three phenotypic groups antigenically distinct, associated, the first one, 
with acute episodes of the infection in different sources (ticks, bovine milk and man), the 
second and the third one with chronic episodes in man (Hackstadt, 1986). Studies in 
literature show that Coxiella possesses four different plasmids, QpH1, QpRS, QpDV and 
QpDG7 (Valková & Kazár, 1995). According to the harboured plasmid and also to DNA 
restriction profiles, C. burnetii can be divided in six genetic groups, variably correlated to 
specific pathotypes (Hendrix et al., 1991). In particular, the groups from I to III, carrying the 
plasmid QpH1, have been isolated from ticks, human cases of acute Q fever, bovine milk 
and birth products of domestic ruminants; the groups IV and V, that respectively possess 
the plasmid QpRS or any plasmid (but, in the latter case, they possess plasmidic sequences 
integrated in the chromosomal DNA), have been associated with abortions of domestic 
ruminants and chronic human cases of endocarditis or hepatitis; the group VI, carrying the 
plasmid QpDG, isolated from rodents, results avirulent in experimental mouse models of 
the infection (Stoenner et al., 1959; Stoenner & Lackman, 1960). Subsequent studies classified 
80 C. burnetii isolates in 20 different genetic profiles by RFLP analysis (analysis of the 
Restriction Fragments Length Polymorphisms). According to this characterization, four 
profiles correspond to the former genetic groups I, IV, V and VI, respectively. In general, the 
RFLPs profiles seem to be associated with the geographical origin of the analysed isolates 
(Jäger et al., 1998). More recent studies based on MST (Multispacer Sequence Typing) 
analysis have variedly confirmed the existence of the aforesaid genetic groups, and 
identified three great monophyletic groups, containing the groups I, II and III, the group IV 
and the group V, respectively. Moreover, these studies seem to confirm the association 
between the plasmid QpDV and acute infections, and between the plasmid QpRS and 
chronic infections, and between specific genotypes and specific courses of the disease 
(Glazunova et al., 2005). Subsequent studies (Beare et al., 2006) performed by microarray 
analysis, further confirm the RFLP genetic groups, and add to the previous groups from I to 
VI, other two big groups (VII and VIII). These studies, underline the importance of the 
polymorphisms of the genes involved in LPS biosynthesis for the virulence of C. burnetii. An 
opposite school of thought instead, considers the characteristics of the host as the main 
cause of the course of the infection in relation to the development of acute or chronic 
diseases. These theories follow on the fact that isolates carrying the plasmid QpH1 have 
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been isolated in France from both acute and chronic human Q fever episodes, while isolates 
deprived of the plasmid QpH1 have been shown to be able to induce an acute syndrome as 
well (Stein & Raoult, 1993). Models of the disease have therefore been proposed in which the 
same isolate is able to cause either the chronic or the acute form of Q fever, exclusively 
according to the host immune response. Particularly, the establishment of the chronic 
syndrome has been associated with a compromised immune state of the host, as for instance 
in case of HIV infection, as well as with an increased production of IL-10, responsible of a 
diminution of the ability of the macrophages to eliminate C. burnetii due to an inhibitory 
effect on the phagosome maturation process (Raoult et al., 2005). Recent data (Russell-
Lodrigue et al., 2009) on the behaviour of C. burnetii isolates belonging to the genetic groups 
I, IV, V and VI in mouse models of Q fever seem however to confirm the theory of the 
association genotype-pathotype. In this study, in fact, strains associated with mice acute 
episodes (group I) have been shown to cause a faster progression of the disease, to induce 
greater pathological changes and to exhibit a higher speed of proliferation in vivo if 
compared to isolates collected from chronic episodes (groups IV and V). Moreover, the 
isolates of the group I, if compared to the others, induce in mouse a stronger immune 
response, characterized by a greater production of inflammatory cytokines for a longer 
period of time. 
3. Sources of infection and routes of transmission 
Sources of infection of Q fever are diverse, and the principal for man is represented by the 
inhalation of infected particles (Fig. 1). Transmission of the bacterium through contaminated 
aerosol can occur following direct contact with infected animals, mostly, with birth products, 
such as amniotic fluid and placenta, which can in turn contaminate the new born or the skin of 
other animals. The extreme resistance of this pathogen to external agents makes it persistent in 
the environment, especially in areas where domestic ruminant farms are present. In fact C. 
burnetii can be easily transmissible through contaminated hay or contaminated dust, and 
spread in the surrounding environment by the wind. For this reason cases of Q fever can also 
be recovered in patients that have not had evident contacts with animals. Human-to-human 
transmission results extremely rare, although cases of transmission of Q fever occurred 
through contact with parturient, through the transplacental way (congenital infection), 
through sexual relations (shown in mouse models of the infection) (Kruszewska & Tylewska-
Wierzbanowska, 1997), blood transfusions (van der Hoek et al., 2010) and intradermic 
inoculation. Ticks are considered as natural reservoirs of C. burnetii. They contribute to the 
maintenance of the infectious agent in the environment by transmitting the disease to animals 
(livestock, pets and wildlife) by bite or by expelling heavy loads of C. burnetii with their feces 
which can contaminate the skin of animals or be inhaled (Kazar, 1996). Cats, dogs, rabbits, 
foxes and rodents are thought to constitute a reservoir for maintenance of infection in the 
domestic cycle of Q fever (Aitken, 1989). The role of rats has not yet been clearly described, 
even if recent data suggest that they might be true reservoirs of the infection, capable of 
independent maintenance of C. burnetii infection cycles thereby contributing to spread and 
transmission of the pathogen (Reusken et al., 2011).  
C. burnetii is secreted in the milk, therefore the ingestion of contaminated food such as raw 
milk and dairy products, represent a possible source of infection for humans (Maurin & 
Raoult, 1999). Hirai and colleagues analysed 147 cheese samples by PCR analysis and found 
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19% of positive results (Hirai et al., 2011). However, when inoculated in mice, none of the 
positive samples allowed the recover of viable C. burnetii. Also, the administration of 
contaminated milk to voluntaries provided contradictory results (Angelakis & Raoult, 2010). 
The notable transmissibility of C. burnetii makes this microorganism extremely dangerous, 
particularly for occupationally exposed workers (veterinarians, slaughterhouse workers and 
farmers) and for laboratory technicians in contact with potentially contaminated specimens 
which therefore require manipulation by experienced personnel in BL3 facilities (Angelakis 
& Raoult, 2010). 
 
Fig. 1. Routes of transmission and pathophysiology of Q fever 
C. burnetii is considered as a potential bioweapon, and is classified as class B agent 
(Madariaga et al., 2003). The high transmissibility of this pathogen, its extreme ability to 
persist in the environment and the aerial route of transmission make it a suitable bacterial 
agent for bioterrorism actions. In fact it has been evaluated that the inhalation of only one 
bacterial cell would be enough to induce the disease in man; moreover, the World Health 
Organization has esteemed that if 50 kg of C. burnetii were spread as an aerosol in an urban 
area of 500.000 inhabitants, 125.000 cases of acute illness, 9.000 cases of chronic Q fever and 
150 dead people would be recorded (World Health Organization, 2004). 
The aerial route of transmission of Q fever also represents the principal mode of infection 
for animals, for which however, unlike humans, an important role in the spread of the 
disease is also played by ticks. Other important ways of infection for animals are 
represented by direct contact with infected animals in the herd, by ingestion of 
contaminated placentas or milk, as well as possible ingestion of infected wild rodents 
(Angelakis & Raoult, 2010). 
4. Pathogenesis 
C. burnetii is a strictly intracellular bacterium capable of infecting different cellular types, 
mainly monocytes and macrophages. Its entry in the host cell is allowed by a mechanism of 
phagocytosis, much more efficient towards the phase II, avirulent, than to the phase I, 
virulent. This difference is due to the fact that the attachment to phase I bacteria is 
exclusively mediated by the integrin 3, while attachment to phase II bacteria is mediated 
both by the integrin 3 and by the complement receptor CR3. The most efficient 
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internalization process determines a best intracellular replication and explains why bacteria 
in phase II grow faster than those in phase I, therefore justifying the conversion of the phase 
I to the phase II following growth in cell cultures. Both types can be recovered in the 
phagosomes, but only the phase I can survive in macrophages, while the phase II is quickly 
eliminated. The ability of C. burnetii to grow inside eukaryotic cells is due to the adaptation 
to the intracellular acidic pH. A pH value of 4.5, indeed, allows the entry of nutrients 
necessary for the metabolic functions of the bacterium, and, at the same time, confers 
protection from the action of numerous antibiotics, by altering their bactericidal activity. In 
macrophages this microorganism locates in vacuoles where its survival and proliferation are 
achieved by the control of phagocytosis and the prevention of phagosome lysosome fusion 
(Angelakis & Raoult, 2010; Raoult et al., 2005). The incomplete maturation of the phagosome 
is due both to the loss of the expression of the cellular marker cathepsin D, and to the 
exogenous production of IL-10, that also interferes with the microbicide activity of the 
macrophages. Interferon- restores the fusion between the phagosome and the lysosome, 
therefore allowing the elimination of C. burnetii. Moreover, it induces the alkalization of the 
vacuoles and controls the metabolism of the ions in the macrophages, inhibiting therefore 
the intracellular bacterial replication. Interferon-, finally contributes to the elimination of 
the infected macrophages through apoptosis, by inducing the expression of TNF on the 
cellular membrane. Following infection, the production of specific immunoglobulins is 
observed; in particular, while the phase I only stimulates the production of IgM, the phase II 
stimulates the production of both IgM and IgG1. The acute syndrome of Q fever determines 
a cell-mediated immune response and the formation of characteristic granulomatous lesions 
with a classical open space in the middle and a fibrin ring ("doughnut" granulomas). The 
control of the acute form includes the action of T cells, that however generally results 
insufficient for the complete elimination of the bacterium (Honstettre et al., 2004). When the 
infection assumes a chronic form, the level of inflammation becomes elevated, while cell-
mediated immunity becomes defective. In fact, it has been observed that in patients affected 
by chronic endocarditis, the production of the inflammatory cytokines TNF and IL-6 is 
increased, while the ability of the lymphocytes to proliferate in response to the stimulation 
with C. burnetii antigen is decreased (Koster et al., 1985). 
5. Epidemiology 
Q fever is a worldwide zoonosis, prevalent in most countries in the world, with the 
exception of New Zealand. The reservoirs are large but partially known, and include many 
domestic and wild mammals, birds and arthropods like ticks (Fig. 2). The main sources of 
infection for man are domestic ruminants, mainly cattle, sheep and goats. Animals are often 
chronically infected, but mostly asymptomatic. In females Coxiella locates in the uterus and 
in the mammary glands and is shed in the environment through birth products, feces, urine 
and milk (Babudieri, 1959; Marrie & Raoult, 2002). Also pets, included dogs, cats and 
rabbits, can transmit the infection to man (Marrie & Raoult, 2002; Stein & Raoult, 1999). 
Animals can be infected by tick bites, ingestion of infected placentas or milk, and through 
the inhalation of contaminated particles. In ticks, as in mammals, C. burnetii is in phase I, 
and therefore highly contagious. Ticks, however, are not considered essential in the 
diffusion of the pathogen to domestic ruminants, but they play an important role in the 
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transmission of Coxiella to the wild fauna, included vertebrates, lagomorphs and birds. 
Moreover they can spread high quantities of the microorganism through their feces, which 
in turn can be inhaled both by man and animals. Age and gender seem to have a role in the 
pathogenesis of Q fever; in particular, studies in man show that subjects less than 15 years 
old are less sensitive than older subjects (Angelakis & Raoult, 2010). Moreover, the number 
of cases in men is 2.5 times greater in comparison to that recorded in women (Gikas et al., 
2010). During pregnancy, in animals, Q fever becomes chronic and C. burnetii remains in the 
uterus and in the mammary glands with the possibility to be reactivated by following 
pregnancies (Marrie et al., 1996). 
 
 
(a) Epidemiology of Q fever in humans (b) Epidemiology of Q fever in animals 
Fig. 2. Epidemiology of Q fever 
5.1 Occurrence of Q fever in man 
Q fever can appear in the form of sporadic cases or outbreaks. It is a notifiable disease, but, 
as the infection is often asymptomatic, and its mild forms can be mistaken for other febrile 
episodes, sporadic forms of the disease are often undiagnosed and the true incidence of Q 
fever is still unknown. Moreover, the indiscriminate use of antibiotics in febrile patients 
hampers the clinical identification of Q fever as well as other rickettsioses and bacterioses. 
To the moment in the European states it is not clear yet the exact entity of Q fever in man, 
and in domestic ruminants. In Europe, preliminary data point out that during 2007, 585 
human cases have been notified, while in 2008 they increased to 1594, with an increase of 
172%. High risk groups include people working with possible infected material 
(slaughterhouse workers, veterinarians, meat-processing workers), persons living in or next 
to farms, and laboratory personnel processing eventually infected organs and tissues 
(Borriello et al., 2010; EFSA Panel on Animal Health and Welfare, 2010). 
In abattoirs and wool-processing plants several epidemic outbreaks have occurred 
worldwide. Australia is considered an endemic area, with an outbreak characterized by 2000 
cases in 1979-1980 (Hunt et al., 1983), while in Uruguay, in 1976, 310 of 360 workers and 
veterinary inspection personnel in a meat-packing plant contracted the disease in a month. 
The outbreak was attributed to the inhalation of contaminated aerosols, probably generated 
by the handling of infected material, as most cases were recorded among workers involved 
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in bone-milling or collection of animal wastes. Three more outbreaks occurred in the same 
meat-packing plant in 1981 and 1984, mainly involving personnel working with 
slaughtering and animal wastes treatment (Somma-Moreira et al., 1987). Epidemics still 
occur in other slaughterhouse workers as well. Recent cases have been reported in New 
South Wales and in Scotland (Gilroy et al., 2001; Wilson et al., 2010). 
Several Q fever epidemics have also been reported in farms and in geographic areas close to 
domestic ruminant herds (cattle, sheep and goats). Q fever cases have also been recorded in 
scientific institutes working with sheep as study models in different countries (Hall et al., 
1982; Meiklejohn et al., 1981), or in human pathology institutes, as reported by Gerth and 
colleagues (1982) in Germany. Major outbreaks also occurred in the years following the 
World War II with estimated 20,000 cases in a two years period (Babudieri, 1959). In an 
urban school in central Israel a large Q fever outbreak has been reported in 2005, possibly 
transmitted by the air conditioning system (Amitai et al., 2005). This report highlights the 
importance to investigate the seroprevalence of Q fever in influenza-like outbreaks 
occurring outside the influenza season. 
In addition to cattle, sheep and goats, parturient cats and newborn kittens can also represent 
a source of infection for man (Marrie et al, 1989). The role of cats in human Q fever 
epidemiology should not be underevaluated as it is the result of a combination of high 
prevalence of C. burnetii in rats and cats’ predatory behavior towards these natural 
reservoirs (Reusken et al., 2011). 
In the USA, 132 cases of Q fever with onset in 2008 have been reported; of these, 117 were 
acute Q fever and 15 were chronic Q fever (NASPHV & CDC, 2011). A serological survey in 
Japan reported prevalence values in healthy humans of 22.2% (Htwe et al., 1992). Moreover 
it has been observed that in Japanese children Q fever is often characterized by a clinical 
expression, mostly represented by atypical pneumonia (Hirai & To, 1998). A recent outbreak 
in the Netherlands started in 2007 and made the European Commission concerned about 
this zoonosis. The Dutch epidemic counted more than 2,200 confirmed human cases of the 
disease and more than 20 people died. In an effort to prevent the disease from spreading 
further, over 50,000 dairy goats were slaughtered and the government launched a 
mandatory animal vaccination campaign at the start of 2009. The main cause of infection has 
been attributed to infected goat and sheep farms located in the southern Brabant province 
(EFSA Panel on Animal Health and Welfare, 2010). 
All the observed epidemics have common risk factors. Particularly, the greatest part of cases 
appear associated with a strict contact with domestic ruminant herds/flocks, mainly sheep 
and goats, both in relationship to the location and to the routes followed by the flocks. A 
great number of cases has often been recorded during or immediately after the period of the 
parturitions. Weather conditions characterized by dry and windy climate seem to play an 
important role in the transmission of the disease. Moreover, another risk factor is 
represented by living and/or working, sporting or performing social activities near 
agricultural zones covered with manure. Finally, also the presence of additional natural 
reservoir of infection (such as wild animals or ticks) near inhabited zones or herds further 
contributes to the maintenance of the pathogen in the environment (Borriello et al., 2010). 
The extreme persistence of C. burnetii in the environment and its diffusion in domestic 
www.intechopen.com
 Zoonosis 
 
72
ruminants and wild animals indicate therefore that good management practices play a 
critical role for the control of Q fever, not only in animals, but also in man (EFSA Panel on 
Animal Health and Welfare, 2010). 
5.2 Occurrence of Q fever in animals 
Q fever has been found in almost all species of domestic animals and many wild species. In 
India, the agent was isolated from amphibians (NASPHV & CDC, 2011) and a python. Q 
fever is endemic in domestic ruminants in the greatest part of the world. Serological surveys 
conducted in endemic areas have revealed a sizable proportion of reactors in the bovine, 
ovine and caprine populations. Although the infection is common, the disease is rare, and it 
has a limited impact on animal health.  
Studies on the seroprevalence of the infection in cattle reported values of 67% in Ontario 
(Lang, 1989) and 40.4% in Sudan (Reinthaler et al., 1988). Similar prevalence values have 
also been reported in sheep and goats flocks in California (Ruppanner et al., 1982) and in 
Sudan (Reinthaler et al., 1988). In Japan, a survey on the presence of Q fever in domestic 
ruminants reported values of 25.4% in healthy cattle, 28.1% in sheep and 23.5% in goat. In 
Japanese bovine herds with reproductive disorders the seroprevalence of Q fever reached 
values of 84.3% (Htwe et al., 1992). In the European states to the moment it is not clear yet 
the exact entity of Q fever in domestic ruminants, since rules or recommendations are not 
harmonized for monitoring and report of the disease (EFSA Panel on Animal Health and 
Welfare, 2010). Epidemiological data on Q fever in animals point out that the general 
prevalence of the disease in domestic ruminants is increased from the 7.4% to the 10.0% 
within the period 2007 -2008. Particularly, the greatest increase has been recorded for goats, 
with values of 9.7% and 15.7% in 2007 and in 2008, respectively. Member States mostly 
affected are Bulgaria, France, Germany and, in particular way, the Netherlands (EFSA Panel 
on Animal Health and Welfare, 2010). In Italy C. burnetii is widely spread in domestic 
ruminants. Molecular analysis of milk in bovine farms has shown a prevalence of the 
infection of 40% (Magnino et al., 2009), and a significant association has been found between 
seropositive animals and abortion (Cabassi et al., 2006).  
Reservoir species of C. burnetii can also be found among wildlife species and arthropods like 
ticks. A serological and molecular study in the Netherlands carried out on brown and black 
rats collected from both livestock farms and urban areas found the 15.8% of the brown rats 
seropositive, and detected C. burnetii DNA in the spleen of 4.9% of the brown rats and 3.0% 
of the black rats by PCR analysis (Reusken et al., 2011). A recent study in Northern Spain 
(Astobiza et al., 2011) identified as potential sources of the disease several wild species, such 
as roe deer, wild boar, European hares and birds, by PCR detection of C. burnetii DNA in 
spleen and liver (5.1%, 4.3%, 9.1% and 1.2%, respectively). Another study also carried out in 
Spain reported higher prevalence values in farmed red deer than in wild red deer (40% vs. 
5.6%), probably indicating that in farmed animals direct contact may increase the risk of C. 
burnetii transmission (Ruiz-Fons et al., 2008). Moreover, several findings from different 
authors show an active role of ticks in maintaining C. burnetii in both wild and peridomestic 
cycles, therefore indirectly representing a risk factor for transmission of Q fever to humans 
(Mediannikov et al., 2010; Parola & Raoult, 2001; Toledo et al., 2009). 
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5.3 Occurrence of Q fever in domestic ruminants in Southern Italy 
In Southern Italy the presence of C. burnetii in bovine and water buffalo herds, and in ovi-
caprine flocks has been reported (Galiero et al., 1996; Parisi et al., 2006; Perugini et al., 2009), 
even if the exact prevalence of this pathogen is still largely unknown. The presence of C. 
burnetii in bovine and water buffalo herds of the Campania region was therefore 
investigated by molecular analysis carried out on aborted foetuses collected during the 
period 2009-2011. 
For this purpose a total of 69 foetuses was analysed. The DNA from several organs (liver, 
lung, abomasum and placenta) was extracted by the DNA mini kit (QIAGEN) and was 
subsequently amplified by a single-tube nested PCR for the detection of C. burnetii (Parisi et 
al., 2006). The foetuses were considered positive when at least one of the sampled organs 
resulted positive. 
The obtained results have shown that the 47% (8/17) of the analyzed bovine foetuses and 
the 29% (15/52) of the analyzed water buffalo foetuses resulted positive to C. burnetii PCR 
detection (Tab. 1). 
 
Species 
Examined 
Foetuses 
Positive 
Foetuses 
Bovine 17 8 
Water buffalo 52 15 
Total 69 23 
Table 1. PCR detection of C. burnetii in bovine and water buffalo foetuses 
Among the 8 positive bovine foetuses, 4 (50%) exhibited the presence of C. burnetii in the 
lungs, 1 (12%) in the liver and 5 (62%) in the abomasum. One foetus exhibited the presence 
of the pathogen both in lungs and liver. 
Among the 15 positive water buffalo foetuses, 8 (53%) exhibited the presence of C. burnetii in 
the liver, 7 (47%) in the lungs, 3 (20%) in the abomasum and 4 (27%) in the placenta. Four 
foetuses exhibited the presence of Coxiella both in liver and lungs, one foetus in liver, lungs 
and placenta, and another foetus in liver, lungs and abomasum (Tab.2). 
 
 
 
 Number of positive samples 
Species 
Analysed 
foetuses 
Lungs Liver Abomasum Placenta 
Bovine 8 4 1 5 0 
Water buffalo 15 7 8 3 4 
Total 23 11 9 8 4 
Table 2. Detection of C. burnetii in organs 
Abortions in bovine and water buffalo herds determine serious economic losses. In Southern 
Italy the incidence of abortions caused by infectious diseases is elevated and clear 
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epidemiological data able to explain the possible causes of this phenomenon are still lacking 
(Capuano et al., 2004). Particularly, among the aetiological agents responsible of abortion, 
preliminary reports indicate that the presence of this pathogen is significant in Southern 
Italy. Indeed, Parisi and colleagues (2006) reported an incidence of C. burnetii in bovine 
herds and ovi-caprine flocks of 6% and 21.5%, respectively, while, in water buffalo herds, 
variable inter-herd prevalence values have been found, ranging from 17 to 23% (Galiero et 
al., 1996; Perugini et al., 2009). 
The data reported in this study confirm the presence of C. burnetii both in bovine and water 
buffalo herds, and point out that this pathogen plays an important role as abortive agent for 
these animal species. Moreover, water buffalo seems to be more susceptible to this pathogen 
rather than cattle. Other studies will be therefore necessary to clarify the epidemiology and 
the pathogenesis of C. burnetii infection both in cattle and water buffalo. Particularly water 
buffalo needs careful investigation as the milk from this species can be used also crude for 
the production of the world famous “mozzarella di bufala” cheese. 
The single-tube nested PCR proved to be an efficient diagnostic method to determine the 
presence of C. burnetii in organs from bovine and water buffalo foetuses. This technique, 
indeed, exhibited enhanced sensitivity, as it is based on the amplification of a secondary 
target sequence within the first run product. The use of a nested PCR therefore might 
increase the possibility to detect C. burnetii DNA in animal tissues, where DNA can easily be 
degraded due to autolysis phenomena, as it often happens in animal foetuses. 
Moreover, these data underline the need of specific diagnostic methods to be carried out 
within proper monitoring plans aiming to provide a careful estimate of C. burnetii 
prevalence and its routes of transmission. 
6. Description of the disease 
Q fever is characterized by a polymorphic clinical spectrum, therefore the diagnosis of the 
disease can only be made if systematic laboratory tests are performed. Several factors are 
likely to influence the course of the infection by C. burnetii. Among these the route of 
infection, the infectious dose, age and gender play a major role (Angelakis & Raoult, 
2010). 
6.1 Q fever in man 
In man the clinical demonstration of the disease can consist in an asymptomatic 
seroconversion, an acute form of the illness, varying from self-limiting fever episodes up to 
granulomatous hepatitis or severe pneumonia, or a chronic form, characterized by 
endocarditis. In the acute forms the incubation period has an average duration of 20 days, 
and the greatest part of cases presents no or mild symptoms. The combination of symptoms 
varies greatly from person to person, and it can include high fevers (up to 39-40°C), severe 
headache, general malaise, myalgia, chills and/or sweats, non-productive cough, nausea, 
vomiting, diarrhoea, abdominal pain and chest pain. Atypical pneumonia is among the most 
common acute manifestations of C. burnetii infection. In some patients serious respiratory 
stresses and diffusion of the bacterium in the pleura can occur. The duration of symptoms 
varies from 10 to 90 days, with a mortality of about 0.5-1.5%. Hepatitis is the most common 
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clinical manifestation of Q fever, and it can be either asymptomatic, or associated with 
hepatomegaly or with characteristic granulomas and prolonged fever (Angelakis & Raoult, 
2010). Rarely (2% of the cases) other symptoms can occur, such as perycarditis, myocarditis, 
neurological symptoms (varying from the most common headaches to meningitis, 
meningoencephalitis or peripheral neuropathies). Dermatological lesions are more common 
than generally thought and they include transient punctiform rashes, maculopapular 
eruptions and, more rarely, erythema nodosum (Raoult et al., 2005). Post-Q fever fatigue 
syndrome can be observed in some (10-25%) acute patients, characterized by constant or 
recurring fatigue, night sweats, severe headaches, photophobia, pain in muscles and joints, 
mood changes and difficulty sleeping. In pregnant women Coxiella settles in the uterus and 
mammary glands, often resulting in pre-term delivery or miscarriage. 
Chronic Q fever is a severe disease occurring in <5% of acutely infected patients. It may 
present soon (within 6 weeks) after an acute infection, or may manifest years later. The 
chronic forms are mostly characterized by endocarditis and vascular infections, less 
frequently by aortic aneurysms and infections of the bone, liver or reproductive organs, 
such as the testes in males. They almost exclusively affect individuals with predisposing 
conditions, such as lesions of cardiac valves, vascular problems or immunodeficiency, and 
symptoms can also occur months or years after the infection. The endocarditis and the 
vascular infections from chronic Q fever generally have a lethal outcome if they are not 
treated with an appropriate antibiotic for a period of at least 18 months up to a life treatment 
(Maurin & Raoult, 1999).  
6.2 Q fever in animals 
In domestic ruminants C. burnetii infection is mostly asymptomatic. During the acute phase 
C. burnetii can be found in blood, lungs, spleen and liver, whereas during chronic Q fever it 
is persistently shed in urine and feces. 
In cattle the main pathological demonstrations of Q fever associated with chronic infections 
are represented by ipofertility, metritis and low birth weight calves, more rarely by 
abortions and stillbirths. In asymptomatic but seropositive herds, Coxiella is almost 
exclusively shed in milk. The excretion can last several months (up to 32) and can be 
continuous or intermittent, and, in some cases, can be associated with chronic subclinical 
mastitis (Rodolakis et al., 2007). In bovine herds with reproductive disorders, infected 
females primarily shed Coxiella through birth products, but also through feces, urine and 
milk (Arricau Bouvery et al., 2003). Elimination of the microorganism through these ways 
can persist for several months, also for subjects that have not exhibited problems during the 
parturition (Berri et al., 2005b). None of these shedding patterns however appears to have a 
predominant role in the eliminatory subjects, often exhibiting one excretion route only. 
Sheep and goats, like cattle, are considered as the main reservoirs of infection for man. They 
almost always result asymptomatic and the most common pathological manifestations of 
chronic Q fever are abortions and stillbirths. In sheep and goats flocks with reproductive 
disorders, animals contemporarily shed the bacterium through vaginal mucus, feces and 
milk. Particularly, in a recent work, goats have been shown to eliminate C. burnetii mostly 
through milk, sheep mainly through vaginal mucus or feces (Rodolakis, 2009). 
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Asymptomatic but seropositive ovine flocks, instead, always resulted negative to C. burnetii 
detection by PCR analysis in bulk tank milk. 
Differences in shedding patterns can explain why sheep and goats are identified more 
frequently than cattle as the main source of infection for man (Rodolakis, 2009). 
7. Diagnostic techniques 
The extreme virulence of C. burnetii requires the use of bio-containment level 3 facilities for 
contaminated specimens processing, and isolation and cultivation of the pathogen should be 
performed by experienced laboratory personnel only (OIE, 2010). Coxiella burnetii can be 
demonstrated in various ways, depending on the type of sample and the purpose of 
investigations (Samuel & Hendrix, 2009; Sidi-Boumedine et al., 2010).  
For human diagnosis of Q fever the most appropriate tests are PCR analysis of whole blood 
samples (most sensitive if blood is collected during the first week of illness; rapidly 
decreasing in sensitivity when antibodies reach a high level) and PCR or 
immunohistochemistry of biopsy specimens. Negative PCR results should not rule out the 
diagnosis, and treatment should not be withheld. Culture isolation of C. burnetii is possible 
in specialized laboratories only, as routine hospital blood cultures cannot detect the 
microorganism. The gold standard serologic test for diagnosis of Q fever is the indirect 
immunofluorescence assay (IFA), performed on paired serum samples collected the first as 
early in the disease as possible (preferably in the first week of symptoms), and the second 2 
to 4 weeks later. The first IgG IFA titer should therefore be typically low or negative, and the 
second should instead exhibit a significant (four-fold) increase. Analysis of two samples is 
necessary as antibodies to C. burnetii may remain elevated for months or longer after the 
disease has resolved, or may be detected in persons previously exposed to antigenically 
related organisms, therefore, interpretation of one sample may be difficult. Humans can 
develop antibody response against both C. burnetii phase I and phase II. In particular, in 
acute infection, an antibody response to C. burnetii phase II antigen is predominant and is 
higher than phase I antibody response; the reverse is true in chronic infection which is 
associated with a rising phase I IgG titer (according to current U.S. case definitions >1:800) 
that is often much higher than phase II IgG (NASPHV & CDC, 2011). 
For animal diagnosis in the context of serial abortions and stillbirths, samples should be 
collected from aborted foetuses, placenta and vaginal discharges soon after abortion or 
parturition. The diagnosis should always include a differential investigation of major 
abortive agents. Early detection of a Q fever outbreak of abortions in a herd or flock and 
correct biocontainment measures are essential to prevent and limit both environmental and 
farm-based routes of infection. A positive case is a herd or flock with clinical signs (abortion 
and/or stillbirth) for which the presence of the agent has been confirmed. As a rule, in the 
veterinary practice, a breeding or a flock can be considered clinically affected by Q fever if 
three circumstances occur: abortions or stillbirths, presence of C. burnetii in samples from 
affected animals (evaluated by Quantitative PCR analysis) and presence of seropositive 
animals (evaluated by ELISA test). EFSA criteria (Sidi-Boumedine et al., 2010) suggested for 
a correct diagnosis of C. burnetii as abortive agent in bovine herds and ovi-caprine flocks are 
summarized in the figures 3 and 4, respectively. 
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Fig. 3. EFSA criteria for a correct diagnosis of Q fever in bovine herds 
7.1 Direct techniques 
For specific laboratory investigations, it may be necessary to isolate the agent. The direct 
methods for the isolation and the identification of the infectious agent require proper 
samples, mainly represented by placenta, vaginal mucus, milk, colostrum, feces and tissues 
of the aborted foetus, such as liver, lung and content of the stomach, collected immediately 
after the abortion.  
Several techniques are available for C. burnetii identification (OIE, 2010), even if they are 
often characterized by low specificity. 
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Fig. 4. EFSA criteria for a correct diagnosis of Q fever in ovi-caprine flocks 
7.1.1 Staining techniques 
These techniques can be carried out in case of abortions suspected to have an infectious 
origin. Best results can be obtained by smears of placental cotyledon prepared on 
microscope slides, but lung, liver and abomasum contents of the aborted foetus or vaginal 
discharges may be used as well. Several methods are suitable for Coxiella identification: 
Stamp, Gimenez, Macchiavello, Giemsa and modified Koster (Gimenez, 1964; Quinn et al., 
1994; Samuel & Hendrix, 2009). The first three techniques give the best results (OIE, 2010). 
These methods are close to the modified Ziehl–Neelsen method involving basic fuchsin to 
stain bacteria. The Stamp method is preferred in veterinary laboratories whereas the 
Gimenez method is very fast for monitoring infected cultural cells in research laboratories. 
Attention must be taken in the interpretation of the results as, microscopically, C. burnetii 
can be confused with Chlamydophila abortus or Brucella spp. When biological staining is 
inconclusive, one of the other methods may be used as a confirmatory test. 
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7.1.2 Isolation of the agent  
These techniques have been abandoned because of their high risk level, even if they can be 
necessary when isolation of Coxiella is required from samples contaminated with more than 
a bacterial species (OIE, 2010). When C. burnetii is present in large numbers and is combined 
with a low contamination rate with other bacteria, direct isolation by inoculation of 
embryonated chicken eggs or cell culture is possible (Maurin & Raoult, 1999; Samuel & 
Hendrix, 2009). A cell microculture system from a commercially available method used for 
virus culture, the shell vial cell culture, has been adapted for isolating strict or facultative 
intracellular bacteria, including C. burnetii. Such a method was described for C. burnetii in 
1990 (Raoult et al., 1990). Suspensions of samples are inoculated into a cell line to observe 
the characteristic vacuoles of C. burnetii multiplication. This method was developed for 
humans but could be adapted for animals. With heavily multi-contaminated samples, such 
as placentas, vaginal discharges, feces, or milk, the inoculation of laboratory animals may be 
necessary as a filtration system. Mice and guinea-pigs are the most appropriate animals for 
this purpose (Scott et al., 1987).  
7.2 Indirect techniques 
Indirect techniques include the indirect immunofluorescence assay (IFA), the ELISA test and 
the complement fixation test (FDC) to be performed on serum samples, or, in the case of the 
ELISA, also on milk samples. Such methods result useful for the screening of high numbers 
of samples, as in the case of entire herds/flocks, but do not provide clear results for single 
animal investigations. In fact some animals can remain seropositive for quite several years 
following acute infection, other animals can shed C. burnetii before seroconversion and 
therefore represent a risk factor for infection, while other animals never seroconvert (Maurin 
& Raoult, 1999). To the moment tests able to discriminate between infected and vaccinated 
animals do not exist yet. 
7.2.1 Indirect Immunofluorescence Assay (IFA) 
In human medicine, the IFA adapted as a micro-immunofluorescence technique is the 
current method for the serodiagnosis of Q fever (Tissot-Dupont et al., 1994). Both phase I 
and phase II C. burnetii antigens are used. The two forms of the infection, acute and chronic, 
have different serological profiles: during acute Q fever, IgG antibodies are elevated against 
phase II only whereas during chronic Q fever, high levels of IgG antibodies to both phase I 
and II of the bacteria are observed (Tissot-Dupont et al., 1994).  
7.2.2 Complement Fixation Test (CFT) 
The test detects complement-fixing antibodies present in the serum. The CFT is specific but 
less sensitive than the ELISA or IFA (Kittelberger et al., 2009; Rousset et al., 2007; 2009). The 
CFT is still used by laboratories in many countries. This method often uses antigen in phase 
II prepared from a mixture of two strains (Nine Mile and Henzerling) or a mixture of 
antigens in phase I and II prepared from Nine Mile strain. 
7.2.3 Enzyme-Linked Immunosorbent Assay (ELISA) 
This technique has a high sensitivity and a good specificity (Kittelberger et al., 2009; Rousset 
et al., 2007; 2009). It is easy to perform. The ELISA is preferred to IFA and CFT, particularly 
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for veterinary diagnosis, because it is convenient for large-scale screening and, is a reliable 
technique for demonstrating C. burnetii antibody in various animal species (Jaspers et al., 
1994; Soliman et al., 1992). Ready-to-use kits are commercially available and can detect anti-
phase II antibodies or both anti-phase I and II antibodies.  
7.3 Specific detection methods 
Detection of C. burnetii in samples can also be achieved by specific immunodetection 
(capture ELISA, immunohistochemistry), in-situ hybridisation or DNA amplification (Jensen 
et al., 2007; Samuel & Hendrix, 2009; Thiele et al., 1992). Immunohistology may be used with 
paraffin-embedded tissues or on acetone-fixed smears (Raoult et al., 1994). The method is an 
indirect immunofluorescence or immunoperoxidase assay using polyclonal C. burnetii 
specific antibodies. Fluorescent in-situ hybridisation using specific oligonucleotide probes 
targeting 16s rRNA may be used on paraffin-embedded tissues, especially placenta samples 
(Jensen et al., 2007).  
C. burnetii detection is today mainly performed by PCR. This method has many advantages 
because it is highly specific and sensitive, it allows the inactivation of the microorganism by 
heating to 90°C for 30-60 min, it allows working on different kinds of samples without the 
need to isolate the bacterium. Unfortunately this method does not allow the isolation of the 
agent. Target sequences for PCR are numerous, and the most used is the IS1111 (accession 
number M80806), which renders the technique even more sensitive as this insertion 
sequence is broadly repeated in the genome of Coxiella. PCR is therefore an effective method 
for the identification of shedding animals. Recently a Real-Time PCR protocol has been set 
up for the identification and the quantification of the number of bacteria present in a 
biological matrix. The quantification of C. burnetii in the abortion products is an extremely 
important information as it is the core part of a correct diagnosis of this pathogen as the real 
cause of the abortion (Sidi-Boumedine et al., 2010). 
7.4 Genotyping methods 
Detection, isolation and identification of C. burnetii can be completed with a molecular 
characterization, useful for epidemiological studies. Several typing methods have been used 
for the characterisation of C. burnetii strains, such as restriction endonuclease of genomic 
DNA (Hendrix et al., 1991), PFGE (Pulsed-Field Gel Electrophoresis) (Jäger et al., 1998), and 
sequence and/or PCR-RFLP (Restriction Fragment Length Polymorphism) analysis of icd, 
com1 and mucZ genes. More recently, the two PCR-based typing methods MLVA (Multi-
Locus Variable number of tandem repeats Analysis) (Arricau-Bouvery et al., 2006; Svraka et 
al., 2006) and multispacer sequence typing (MST) (Glazunova et al., 2005) are gaining 
importance for several reasons. Indeed they permit the typing of C. burnetii without the 
need for isolation of the organism. Moreover they exhibit high discriminating power with 
relatively low costs. MLVA analysis is currently the reference method for the genetic 
characterization of important pathogens such as M. tuberculosis, B. anthracis and Y. pestis. 
Recent studies have shown that the application of this technique to C. burnetii isolates both 
of animal and human origin allowed the identification of 36 different genetic profiles on a 
total of 42 isolates (Arricau-Bouvery et al., 2006). Moreover, databases have been 
established, http: //minisatellites.u-psud.fr/MLVAnet/ and http://ifr48.timone.univ-
mrs.fr for MLVA and MST, respectively. The availability of such databases allows easy 
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inter-laboratory comparisons which might lead to a better understanding of the propagation 
of C. burnetii isolates.  
These tools are very useful for epidemiological investigation, particularly to clarify links 
regarding sources of infection, for better understanding of the epidemiological emerging 
factors, and to a lesser extent, for evaluating control measures. 
8. Therapy and prophylaxis 
In man doxycycline is the first line treatment for all adults, and for children with severe 
illness. Doxycycline is most effective at preventing severe complications if it is started early 
in the course of disease. Failure to respond to this antibiotic indicates that C. burnetii is not 
the aetiological agent of the illness, as resistance to doxycycline has never been documented. 
The recommended dosage for acute Q fever in adults is 100 mg every 12 hours, while for 
children under 45 kg is 2.2 mg/kg of body weight given twice a day. Standard duration of 
treatment is 2-3 weeks, or for at least three days after the fever subsides, or until there is 
evidence of clinical improvement. The recommended treatment for adults affected by 
chronic Q fever includes 100 mg of doxycycline every 12 hours and 200 mg of 
hydroxychloroquine every 8 hours. Standard duration of treatment is 18 months (NASPHV 
& CDC, 2011). 
In animals little information is available on the effectiveness of antibiotic treatments, which 
are often used for reducing the number of abortions and the level of elimination of C. 
burnetii during parturition. Antimicrobial treatment is in fact used mainly to minimize 
shedding of the organism in the placenta and birth fluids rather to eliminate it. This 
treatment doesn't prevent entirely neither the abortion (Berri et al., 2005a), nor the 
elimination of Coxiella during parturition (Arricau-Bouvery & Rodolakis, 2005). The 
prophylaxis based on antibiotic treatment provides therefore the advantage to reduce the 
risk of abortion, but it doesn't determine the eradication of the disease. In fact, following 
antibiotic treatment, the animals can still shed Coxiella even if they result clinically recovered 
from the disease. 
During Q fever outbreaks the spreading of Coxiella in the herd can be prevented or at least 
reduced by applying control measures including severe hygiene protocols, aiming to 
prevent environmental contamination (manure composting, fight against natural reservoirs, 
separation of the areas used for parturition and new born, ready elimination of vaginal 
discharges and abortion products) and possible culling of seropositive and/or shedding 
animals. 
Vaccination seems to be the only efficient strategy for the control of the disease. Currently 
two typologies of vaccines exist, one developed against the phase I (virulent), and one 
against the phase II (avirulent). The commercial available products are Q-VAX ® (for human 
use), Coxevac ® (for veterinary use) and Chlamivax FQ ® (for veterinary use, developed 
also against Chlamydophila abortus). The use of vaccine does not avoid the risk of shedding of 
the microorganism from infected animals. Vaccination is therefore suitable only for 
seronegative herds/flocks. The use of the anti-phase I vaccine in the veterinary practice 
results useful not only for the control of the disease inside the herd/flock, but also effective 
against the spreading of the infection in the neighbouring herds as well as in man. 
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9. Conclusion 
The numerous cases of Q fever in animals and in man recently occurred in the Netherlands 
renewed the interest of the sanitary authorities and of the scientific community on a disease 
for too long neglected. The presence of this pathology worldwide and the underestimation 
of this disease highlight the need of specific serological and molecular investigations 
including careful examination of all the ipofertility and abortion cases recorded in domestic 
ruminant herds/flocks. Epidemiological data should be used to set up effective monitoring 
and prophylaxis strategies for the control of Q fever. Particular attention should be posed on 
the control of this pathology in domestic and wildlife animals, aiming to contain the 
economic and sanitary impact that the uncontrolled spread of Q fever would have on 
human health. 
10. References 
Aitken, I.D. (1989). Clinical aspects and prevention of Q fever in animals. European Journal of 
Epidemiology, Vol.5, No.4, (December), pp.420-424, ISSN 
Amitai, Z., Bromberg, M., Bernstein, M., Raveh, D., Keysary, A., David, D., Pitlik, S., 
Swerdlow, D., Massung, R., Rzotkiewicz, S., Halutz, O. & Shohat, T. (2005). A large 
Q fever outbreak in an urban school in central Israel. Clinical Infectious Diseases, 
Vol.50, No.11, (June 1), pp. 1433-1438, ISSN 1537-6591 
Angelakis, E. & Raoult, D. (2010). Q Fever. Veterinary Microbiology, Vol.140, No.3-4, (January 
27), pp. 297-309, ISSN 0378-1135 
Arricau Bouvery, N., Souriau, A., Lechopier, P. & Rodolakis, A. (2003). Experimental Coxiella 
burnetii infection in pregnant goats: excretion routes. Veterinary Research, Vol.34, 
No.4, (July-August), pp. 423-433, ISSN 0378-1135 
Arricau-Bouvery, N. & Rodolakis, A. (2005). Is Q fever an emerging or reemerging zoonosis? 
Veterinary Research, Vol.36, No.3, (May-June), pp. 327-349, ISSN 0378-1135 
Arricau-Bouvery, N., Hauck, Y., Bejaoui, A., Frangoulidis, D., Bodier, C.C., Souriau, A., 
Meyer, H., Neubauer, H., Rodolakis, A. & Vergnaud, G. (2006). Molecular 
characterization of Coxiella burnetii isolates by infrequent restriction site-PCR and 
MLVA typing. BMC Microbiology, Vol.6, (April 26), pp. 38, ISSN 1471-2180 
Astobiza, I., Barral, M., Ruiz-Fons, F., Barandika, J.F., Gerrikagoitia, X., Hurtado, A. & 
García-Pérez, A.L. (2011). Molecular investigation of the occurrence of Coxiella 
burnetii in wildlife and ticks in an endemic area. Veterinary Microbiology, Vol.147, 
No.1-2, (January 10), pp. 190-194, ISSN 0378-1135 
Babudieri, B. (1959). Q fever. A zoonosis. Advances in Veterinary Science, Vol.5, pp. 82-182, 
ISSN 0096-7653 
Beare, P.A., Samuel, J.E., Howe, D., Virtaneva, K., Porcella, S.F. & Heinzen, R.A. (2006). 
Genetic diversity of the Q fever agent, Coxiella burnetii, assessed by microarray-
based whole-genome comparisons. Journal of Bacteriology, Vol.188, No.7, (April), pp. 
2309-2324, ISSN 1098-5530 
Berri, M., Crochet, D., Santiago, S. & Rodolakis, A. (2005a). Spread of Coxiella burnetii 
infection in a flock of sheep after an episode of Q fever. The Veterinary Record, 
Vol.157, No.23, (December 3), pp. 737-740, ISSN 0042-4900 
www.intechopen.com
 Coxiella burnetii 
 
83 
Berri, M., Rousset, E., Hechard, C., Champion, J.L., Dufour, P., Russo, P. & Rodolakis, A. 
(2005b). Progression of Q fever and Coxiella burnetii shedding in milk after an 
outbreak of enzootic abortion in a goat herd. The Veterinary Record, Vol.156, No.17, 
(April 23), pp. 548-549, ISSN 0042-4900 
Borriello, G., Iovane, G. & Galiero, G. (2010). La febbre Q negli animali domestici. Large 
Animal Review, Vol.16, pp. 273-283, ISSN 1124-4593 
Burnet, F.M. & Freeman, M. (1937). Experimental studies on the virus of “Q” fever. Reviews 
of Infectious Diseases, Vol.5, No.4, (July August), PP. 299-305, ISSN 0162-0886 
Cabassi, C.S., Taddei, S., Donofrio, G., Ghidini, F., Piancastelli, C., Flammini, C.F. & 
Cavirani, S. (2006). Association between Coxiella burnetii seropositivity and abortion 
in dairy cattle of Northern Italy. New Microbiologica, Vol.29, No.3, (July), pp. 211-
214, ISSN 1121-7138 
Capuano, F., Parisi, A., Cafiero, M., Picaro, L. & Fenizia, D. (2004). Coxiella burnetii: what is 
the reality?. Parassitologia Vol.46, No.1-2, (June), pp. 131–134, ISSN: 0048-2951 
Derrick, E.H. (1937). Q fever, a new fever entity clinical features, diagnosis and laboratory 
investigation. The Medical Journal of Australia, Vol.2, pp. 281-299, ISSN 1326- 5377 
EFSA Panel on Animal Health and Welfare (AHAW), (2010) Scientific opinion on Q fever. 
EFSA Journal Vol.8, No.5, (May 12), pp. 1595-1708, ISSN 1831-4732 
Galiero, G., Goffredi, C.G. & D’Orazi, A. (1996). Epidemiology of Q fever: seroprevalence in 
buffalo dairies of Salerno province. Selezione Veteterinaria, Vol.6, pp. 407-412, ISSN 
0037-1521 
Gerth, H.J., Leidig, U. & Riemenschneider, T. (1982). Q-fever epidemic in an institute of 
human pathology. Deutsche medizinische Wochenschrift, Vol.107, No.37, (September 
17), pp. 1391-5, ISSN 1439-4413 
Gikas, A., Kokkini, S. & Tsioutis, C. (2010). Q fever: clinical manifestations and treatment. 
Expert Review of Anti-Infective Therapy, Vol.8, No.5, (May), pp. 529-539, ISSN: 1478-
7210 
Gilroy, N., Formica, N., Beers, M., Egan, A., Conaty, S. & Marmion, B. (2001). Abattoir-
associated Q fever: a Q fever outbreak during a Q fever vaccination program. The 
Australian and New Zealand Journal of Public Health, Vol.25, No.4, (August), pp. 362-
367, ISSN 1753-6405 
Gimenez, D.F. (1964). Staining rickettsiae in yolk-sack cultures. Stain technology, Vol.39, 
(May), pp. 135–140, ISSN 0038-9153 
Glazunova, O., Roux, V., Freylikman, O., Sekeyova, Z., Fournous, G., Tyczka, J., Tokarevich, 
N., Kovacava, E., Marrie, T.J. & Raoult, D. (2005). Coxiella burnetii genotyping. 
Emerging Infectious Disease, Vol.11, No.8, (August), pp. 1211-1217, ISSN 1080-6059 
Hackstadt, T. (1986). Antigenic variation in the phase I lipopolysaccharide of Coxiella burnetii 
isolates. Infection and Immunity, Vol.52, No.1, (April), pp. 337-340, ISSN 1098-5522 
Hall, C.J., Richmond, S.J., Caul, E.O., Pearce, N.H. & Silver, I.A. (1982). Laboratory outbreak 
of Q fever acquired from sheep. The Lancet, Vol.1, No.8279, (May 1), pp. 1004-1006, 
ISSN 0140-6736 
Hendrix, L.R., Samuel, J.E. & Mallavia, L.P. (1991). Differentiation of Coxiella burnetii isolates 
by analysis of restriction-endonuclease-digested DNA separated by SDS-PAGE. 
Journal of General Microbiology, Vol.137, No.2, (February), pp. 269-276, ISSN 0022-
1287 
www.intechopen.com
 Zoonosis 
 
84
Hirai, K. & To, H. (1998). Advances in the understanding of Coxiella burnetii infection in 
Japan. Journal of Veterinary Medical Science, Vol.60, No.7, (July), pp. 781-790, ISSN 
0916-7250 
Hirai, A., Nakama, A., Chiba, T. & Kai, A. (2011). Development of a Method for Detecting 
Coxiella burnetii in Cheese Samples. Journal of Veterinary Medical Science, (October 7), 
Epub ahead of print, ISSN 0916-7250 
Honstettre, A., Ghigo, E., Moynault, A., Capo, C., Toman, R., Akira, S., Takeuchi, O., Lepidi, 
H., Raoult, D. & Mege, J.L. (2004). Lipopolysaccharide from Coxiella burnetii is 
involved in bacterial phagocytosis, filamentous actin reorganization, and 
inflammatory responses through Tolllike receptor 4. Journal of Immunology, Vol.172, 
No.6, (March 15), pp. 3695-3703, ISSN 1550- 6606 
Htwe, K.K., Amano, K., Sugiyama, Y., Yagami, K., Minamoto, N., Hashimoto, A., 
Yamaguchi, T., Fukushi, H. & Hirai, K. (1992). Seroepidemiology of Coxiella burnetii 
in domestic and companion animals in Japan. The Veterinary Record, Vol.131, No.21, 
(November 21), pp. 490, ISSN 0042-4900 
Hunt, J.G., Field, P.R. & Murphy, A.M. (1983). Immunoglobulin responses to Coxiella burnetii 
(Q fever): single-serum diagnosis of acute infection, using an immunofluorescence 
technique. Infection and Immunity, Vol.39, No.2, (February), pp. 977-981, ISSN 1098-
5522 
Jäger, C., Willems, H., Thiele, D. & Baljer G. (1998). Molecular characterization of Coxiella 
burnetii isolates. Epidemiology and Infection, Vol.120, No.2, (March), pp. 157-164, 
ISSN 1469-4409 
Jaspers, U., Thiele, D. & Krauss, H. (1994). Monoclonal antibody based competitive ELISA 
for the detection of specific antibodies against Coxiella burnetii in sera from different 
animal species. Zentralblatt für Bakteriologie, Vol.281, No.1, (June), pp. 61–66, ISSN 
0934-8840 
Kazar, J. (1996). Q fever. In: Rickettsiae and Rickettsial Diseases, Kazar, J., Toman, R. (Eds.), 
353-362, Slovak Academy of Sciences, ISBN 978-052-1821-49-0, Bratislava, Slovakia  
Jensen, T.K., Montgomery, D.L., Jaeger, P.T., Lindhardt, T., Agerholm, J.S., Bille-Hansen, V. 
& Boye M. (2007). Application of fluorescent in situ hybridisation for 
demonstration of Coxiella burnetii in placentas from ruminant abortions. Acta 
Pathologica, Microbiologica et Immunologica Scandinavica, Vol.115, No., pp. 347–353, 
ISSN 1600-0463. 
Kittelberger, R., Mars, J.,Wibberley, G., Sting, R., Henning, K., Horner, G.W., Garnett, K.M., 
Hannah, M.J., Jenner, J.A., Pigott, C.J. & O’keefe, J.S. (2009). Comparison of the Q 
fever complement fixation test and two commercial enzyme-linked immunosorbent 
assays for the detection of serum anibodies against Coxiella burnetii (Q-fever) in 
ruminants: Recommandations for use of serological tests on imported animals in 
New Zealand. New Zealand Veterinary Journal, Vol.57, No.5, (October), pp. 262–268, 
ISSN 1176-0710 
Koster, F.T., Williams, J.C. & Goodwin, J.S. (1985). Cellular immunity in Q fever: specific 
lymphocyte unresponsiveness in Q fever endocarditis. Journal of Infectious Diseases, 
Vol.152, No.6, (December), pp. 1283-1289, ISSN 1537-6613 
www.intechopen.com
 Coxiella burnetii 
 
85 
Kruszewska, D. & Tylewska-Wierzbanowska, S. (1997). Isolation of Coxiella burnetii from 
bull semen. Research in Veterinary Science, Vol.62, No.3, (May June), pp. 299-300, 
ISSN 0034-5288 
Lang, G.H. (1989). Q fever: an emerging public health concern in Canada. Canadian Journal of 
Veterinary Research, Vol.53, No.1, (January), pp.1-6, ISSN 0830-9000 
Madariaga, M.G., Rezai, K., Trenholme, G.M. & Weinstein, R.A. (2003). Q fever: a biological 
weapon in your backyard. The Lancet infectious diseases, Vol.3, No.11, (November), 
pp. 709-721, ISSN 1474-4457 
Magnino, S., Vicari, N., Boldini, M., Rosignoli, C., Nigrelli, A., Andreoli, G., Pajoro, M. & 
Fabbi, M. (2009). Rilevamento di Coxiella burnetii nel latte di massa di alcune 
aziende bovine lombarde. Large Animal Review, Vol.15, pp. 3-6, ISSN 1124-4593 
Marrie, T.J., Langille, D., Papukna, V. & Yates, L. (1989). Truckin' pneumonia--an outbreak 
of Q fever in a truck repair plant probably due to aerosols from clothing 
contaminated by contact with newborn kittens. Epidemiology and Infection, Vol.102, 
No.1, (February), pp. 119-127, ISSN 1469-4409 
Marrie, T.J., Stein, A., Janigan, D. & Raoult, D. (1996). Route of infection determines the 
clinical manifestations of acute Q fever. Journal of Infectious Diseases, Vol.173, No.2, 
(February), pp. 484-487, ISSN 1537-6613 
Marrie, T.J. & Raoult, D. (2002). Update on Q fever, including Q fever endocarditis. Current 
Clinical Topics in Infectious Diseases, Vol.22, pp. 97-124, ISSN 0195-3842 
Maurin, M. & Raoult, D. (1999). Q fever. Clinical Microbiology Reviews, Vol.12, No.4, 
(October), pp. 518-553, ISSN 0893-8512 
Mediannikov, O., Fenollar, F., Socolovschi, C., Diatta, G., Bassene, H., Molez, J.F., Sokhna, 
C., Trape, J.F. & Raoult, D. (2010). Coxiella burnetii in humans and ticks in rural 
Senegal. PLoS Neglected Tropical Diseases, Vol.4, No.4, (Apr 6), e654, ISSN 1935-2735 
Meiklejohn, G., Reimer, L.G., Graves, P.S. & Helmick, C. (1981). Cryptic epidemic of Q fever 
in a medical school. Journal of Infectious Diseases, Vol.144, No.2, (August), pp. 107-
113, ISSN 1537-6613 
NASPHV (National Association of State Public Health Veterinarians, Inc.) & CDC (Centers 
for Disease Control and Prevention), (2011). Compendium of measures to prevent 
disease associated with animals in public settings, 2011: National Association of 
State Public Health Veterinarians, Inc. MMWR Recommendations and reports, Vol.60, 
No.RR-4, (May 6), pp. 1-24, ISSN 1545-8601 
OIE, Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, (2010). Q fever, 
World Organisation for Animal Health, Chapter 2.1.12, (May), pp.1-13, ISBN 978-
92-9044-718-4 
Parisi, A., Fraccalvieri, R., Cafiero, M., Miccolupo ,A., Padalino, I., Montagn,a C., Capuano, 
F. & Sottili, R. (2006). Diagnosis of Coxiella burnetii-related abortion in Italian 
domestic ruminants using single-tube nested PCR. Veterinary Microbiology, Vol.118, 
No.1-2, (November 26), pp. 101-106, ISSN 0378-1135 
Parola, P. & Raoult, D. (2001). Ticks and tickborne bacterial diseases in humans: an emerging 
infectious threat. Clinical Infectious Diseases, Vol.32, No.6, (March 15), pp. 897-928, 
ISSN 1537-6591 
Perugini, A.G., Capuano, F., Esposito, A., Marianelli, C., Martucciello, A., Iovane, G. & 
Galiero, G. (2009). Detection of Coxiella burnetii in buffaloes aborted foetuses by 
www.intechopen.com
 Zoonosis 
 
86
IS111 DNA amplification: a preliminary report. Research in Veterinary Science, 
Vol.87, No.2, (October), pp. 189-191, ISSN 0034-5288 
Philip, C.B. (1948). Comments on the name of the Q fever organism. Public Health Reports, 
Vol.63, pp. 58-59, ISSN 0033-3549 
Quinn, P.J., Carter, M.E., Markey, B. & Carter, G.R. (1994). Bacterial pathogens: microscopy, 
culture and identification. In: Clinical Veterinary Microbiology. Wolfe Publishing, 
Mosby-Year Book Europe Limited, 21–30, ISBN 978-072-3417-11-8, London 
Raoult, D., Vestris, G. & Enea, M. (1990). Isolation of 16 strains of Coxiella burnetii from 
patients by using a sensitive centrifugation cell culture system and establishment of 
the strains in HEL cells. Journal of Clinical Microbiology, Vol.28, pp. 2482-2484, ISSN 
0095-1137 
Raoult, D., Laurent, J.C. & Mutillod, M. (1994). Monoclonal antibodies to Coxiella burnetii for 
antigenic detection in cell cultures and in paraffin-embedded tissues. American 
Journal of Clinical Pathology, Vol.101, No.3, (March), pp. 318–320, ISSN 1943-7722 
Raoult, D., Marrie, T. & Mege, J. (2005). Natural history and pathophysiology of Q fever. The 
Lancet infectious diseases, Vol.5, No.4, (April), pp. 219-226, ISSN 1474-4457 
Reinthaler, F.F., Mascher, F., Sixl, W. & Arbesser, C.H. (1988). Incidence of Q fever among 
cattle, sheep and goats in the Upper Nile province in southern Sudan. The 
Veterinary Record, Vol.122, No.6, (February 6), pp. 137, ISSN 0042-4900 
Reusken, C., van der Plaats, R., Opsteegh, M., de Bruin, A. & Swart, A. (2011). Coxiella 
burnetii (Q fever) in Rattus norvegicus and Rattus rattus at livestock farms and urban 
locations in the Netherlands; could Rattus spp. represent reservoirs for 
(re)introduction? Preventive Veterinary Medicine, Vol.101, No.1-2, (august 1), pp.124-
130, ISSN 0167-5877 
Rodolakis, A., Berri, M., Héchard, C., Caudron, C., Souriau, A., Bodier, C.C., Blanchard, B., 
Camuset, P., Devillechaise, P., Natorp, J.C., Vadet, J.P. & Arricau-Bouvery, N. 
(2007). Comparison of Coxiella burnetii shedding in milk of dairy bovine, caprine, 
and ovine herds. Journal of Dairy Science, Vol.90, No.12, (December), pp. 5352- 5360, 
ISSN 0022-0302 
Rodolakis, A. (2009). Q Fever in dairy animals. Annals of the New York Academy of Sciences, 
Vol.1166, (May), pp. 90-93, ISSN 1749-6632 
Rousset, E., Durand, B., Berri, M., Dufour, P., Prigent, M., Russo, P., Delcroix, T., Touratier, 
A., Rodolakis, A. & Aubert, M.F. (2007). Comparative diagnostic potential of three 
serological tests for abortive Q fever in goat herds. Veterinary Microbiology, Vol.124, 
No.3-4, (October 6), pp. 286–297, ISSN 0378-1135 
Rousset, E., Berri, M., Durand, B., Dufour, P., Prigent, M., Delcroix, T., Touratier, A. & 
Rodolakis, A. (2009). Coxiella burnetii shedding routes and antibody response after 
outbreaks of Q fever-induced abortion in dairy goat herds. Applied and 
Environmental Microbiology, Vol.75, No.2, (January), pp. 428–433, ISSN  
Ruppanner, R., Brooks, D., Franti, C.E., Behymer, D.E., Morrish, D. & Spinelli, J. (1982). Q 
fever hazards from sheep and goats used in research. Archives of Environmental 
Health, Vol.37, No.2, (March - April), pp. 103-110, ISSN 0003-9896 
Ruiz-Fons, F., Rodríguez, O., Torina, A., Naranjo, V., Gortázar, C. & de la Fuente, J. (2008). 
Prevalence of Coxiella burnetti infection in wild and farmed ungulates. Veterinary 
Microbiology, Vol.126, No.1-3, (January 1), pp. 282-286, ISSN 0378-1135 
www.intechopen.com
 Coxiella burnetii 
 
87 
Russell-Lodrigue, K.E., Andoh, M., Poels, M.W., Shive, H.R., Weeks, B.R., Zhang, G.Q., 
Tersteeg, C., Masegi, T., Hotta, A., Yamaguchi, T., Fukushi, H., Hirai, K., 
McMurray, D.N. & Samuel, J.E. (2009). Coxiella burnetii isolates cause genogroup-
specific virulence in mouse and guinea pig models of acute Q fever. Infection and 
Immunity, Vol.77, No.12, (December), pp. 5640-5650, ISSN 1098-5522 
Samuel, J.E. & Hendrix, L.R. (2009). Laboratory maintenance of Coxiella burnetii. Current 
Protocols in Microbiology, Vol.6C, No.suppl.15, pp. 1–16, ISSN 1934-8533 
Scott, G.H., Williams, J.C. & Stephenson, E.H. (1987). Animal models in Q fever: 
pathological responses of inbred mice to phase I Coxiella burnetii. Journal of General 
Microbiology, Vol.133, No. 3, (March), pp. 691–700, ISSN 0022-1287 
Sidi-Boumedine, K., Rousset, E., Henning, K., Ziller, M., Niemczuck, K., Roest, H.I.J. & 
Thiéry, R. (2010). Development of harmonised schemes for the monitoring and 
reporting of Q-fever in animals in the European Union. EFSA Scientific Report on 
Question No EFSA-Q-2009-00511., (May 5), pp. 1-48. Available from: 
http://www.efsa.europa.eu  
Soliman A.K., Botros B.A. & Watts D.M. (1992). Evaluation of a competitive immunoassay 
for detection of Coxiella burnetii antibody in animal sera. Journal of Clinical 
Microbiology, Vol.30, No.6, (June), pp.1595–1597, ISSN 0095-1137 
Somma-Moreira, R.E., Caffarena, R.M., Somma, S., Pérez, G. & Monteiro, M. (1987). Analysis 
of Q fever in Uruguay. Reviews of Infectious Diseases, Vol.9, No.2, (March – April), 
pp. 386-387, ISSN 0162-0886 
Stein, A. & Raoult, D. (1993). Lack of pathotype specific gene in human Coxiella burnetii 
isolates. Microbial Pathogenesis, Vol.15, No.3, (September), pp. 177-185, ISSN 0882-
4010 
Stein, A. & Raoult, D. (1999). Pigeon pneumonia in Provence. A bird borne Q fever outbreak. 
Clinical Infectious Diseases, Vol.29, No.3, (September), pp. 617-620, ISSN 1537-6591 
Stoenner, H.G., Holdenried, R., Lackman, D. & Orsborn, J.S. Jr. (1959). The occurrence of 
Coxiella burnetii, Brucella, and other pathogens among fauna of the Great Salt Lake 
Desert in Utah. The American Journal of Tropical Medicine and Hygiene, Vol.8, 
(September), pp. 590-596, ISSN 0002-9637 
Stoenner, H.G. & Lackman, D.B. (1960). The biologic properties of Coxiella burnetii isolated 
from rodents collected in Utah. American journal of hygiene, Vol.71, (January), pp. 45-
51, ISSN 0096-5294 
Svraka, S., Toman, R., Skultety, L., Slaba, K. & Homan, W.L. (2006). Establishment of a 
genotyping scheme for Coxiella burnetii. FEMS Microbiology Letters, Vol.254, No.2, 
(January), pp. 268–274, ISSN 1574-6968 
Thiele, D., Karo, M. & Krauss, H. (1992). Monoclonal antibody based capture ELISA/ELIFA 
for detection of Coxiella burnetii in clinical specimens. European Journal of 
Epidemiology, Vol.8, No.4, (July), pp. 568–574, ISSN 1573-7284 
Tissot-Dupont, H., Thirion, X. & Raoult, D. (1994). Q fever serology: cutoff determination for 
microimmunofluorescence. Clinical and Diagnostic Laboratory Immunology, Vol.1, 
No.2, (March), pp. 189–196. ISSN 1098-6588 
Toledo, A., Jado, I., Olmeda, A.S., Casado-Nistal, M.A., Gil, H., Escudero, R. & Anda, P. 
(2009). Detection of Coxiella burnetii in ticks collected from Central Spain. Vector-
Borne and Zoonotic Diseases, Vol.9, No.5, (October), pp. 465-468, ISSN 1530-3667 
www.intechopen.com
 Zoonosis 
 
88
Valková, D. & Kazár, J. (1995). A new plasmid (QpDV) common to Coxiella burnetii isolates 
associated with acute and chronic Q fever. FEMS Microbiology Letters, Vol.125, 
No.2-3, (January 15), pp. 275-280, ISSN 1574-6968 
van der Hoek, W., Dijkstra, F., Schimmer, B., Schneeberger, P.M., Vellema, P., Wijkmans, C., 
ter Schegget, R., Hackert, V. & van Duynhoven, Y. (2010). Q fever in the 
Netherlands: an update on the epidemiology and control measures. Euro 
Surveillance, Vol.25, No.12, (March 25), pp. 15-26, ISSN 1560-7917 
Wilson, L.E., Couper, S., Prempeh, H., Young, D., Pollock, K.G., Stewart, W.C., Browning, 
L.M. & Donaghy, M. (2010). Investigation of a Q fever outbreak in a Scottish co-
located slaughterhouse and cutting plant. Zoonoses and Public Health, Vol.57, No.7-8, 
(December), pp. 493-498, ISSN 1863-2378 
World Health Organization, (2004). Public health response to biological and chemical 
weapons: In. WHO guidance, 2nd ed., ISBN 978-924-1546-15-7, Geneva 
www.intechopen.com
Zoonosis
Edited by Dr. Jacob Lorenzo-Morales
ISBN 978-953-51-0479-7
Hard cover, 436 pages
Publisher InTech
Published online 04, April, 2012
Published in print edition April, 2012
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
Zoonotic diseases are mainly caused by bacterial, viral or parasitic agents although "unconventional agents"
such as prions could also be involved in causing zoonotic diseases. Many of the zoonotic diseases are a public
health concern but also affect the production of food of animal origin thus they could cause problems in
international trade of animal-origin goods. A major factor contributing to the emergence of new zoonotic
pathogens in human populations is increased contact between humans and animals. This book provides an
insight on zoonosis and both authors and the editor hope that the work compiled in it would help to raise
awareness and interest in this field. It should also help researchers, clinicians and other readers in their
research and clinical usage.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Giorgia Borriello and Giorgio Galiero (2012). Coxiella burnetii, Zoonosis, Dr. Jacob Lorenzo-Morales (Ed.),
ISBN: 978-953-51-0479-7, InTech, Available from: http://www.intechopen.com/books/zoonosis/coxiella-burnetii
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
